+1 (704) 266-3234

Advanced Wound Dressings - 5EU Analysis And Market Forecasts

Published on: May 2015 | From USD $4450 | Published By: GLOBAL DATA | Number Of Pages:

Advanced Wound Dressings - 5EU Analysis and Market Forecasts


Advanced dressings have steadily replaced traditional bandages and gauze materials in the treatment of a variety of wound indications, such as trauma wounds, burns, and chronic ulcerations. As fluid management, infection control, and physical protection become increasingly critical in wound healing, advanced dressings enjoy a greater role in standard therapy.

This report focuses on nine market categories within the advanced wound dressings segment, which are foams, alginates, semi-permeable films, hydrocolloids, hydrogels, hydrofibers, collagens, superabsorbents, and wound contact layers. The 5EU advanced dressings market has been estimated in this report, which covers France, Germany, Italy, Spain, and the UK up to 2021. The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of advanced dressings in the 5EU region.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.


Key Questions Answered

- (Q). What is the current and future market outlook for advanced dressings in the 5EU region? (Q). What trends are affecting the advanced dressings market?
- (Q). Which are the key, high growth markets? (Q). What advanced dressings segments are growing the fastest?
- (Q). What are the unmet needs? (Q). What is the scope for more innovation and what are the end-users looking for in their products?
- (Q). What are some of the newer innovations that may fulfill these unmet needs? (Q). What are the physician perceptions? Smith & Nephew, 3M, Mölnlycke, ConvaTec and Coloplast currently dominate the global advanced dressings market.
- (Q). What are their market shares in the 5EU economies and which companies constitute the remainder of the market?

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.2 Anatomy & Physiology
3.3 Indications
3.3.1 Acute Wounds
3.3.2 Chronic Wounds
3.3.3 Surgical Wounds
3.4 Clinical Outcomes
3.4.1 Normal Wound Healing Process
3.4.2 Key Factors to Wound Management
3.5 Applications of Technology
3.5.1 Traditional Wound Care Products
3.5.2 Current Advanced Wound Dressing Modalities
3.5.3 Biologics & Tissue-Engineered Products
3.5.4 Device and Equipment Therapies
3.6 Advantages and Disadvantages of Technology
3.7 Market Access
3.7.1 Overview
3.7.2 Adoption of Technology
3.7.3 Brand Loyalty and Relationships with Manufacturers
3.7.4 Purchasing Decisions
3.7.5 Influence of Clinical Trials
3.8 Regulatory Process
3.8.1 Overview
3.8.2 Europe
3.9 Reimbursement
3.9.1 Overview
3.9.2 France
3.9.3 Germany
3.9.4 Italy
3.9.5 Spain
3.9.6 United Kingdom
3.10 Industry Trends
3.10.1 Regulatory Issues & Recalls
3.10.2 Mergers, Acquisitions, and Key Partnerships
3.11 Economic Impact
3.11.1 Indirect Costs
3.11.2 Direct Costs
4 Unmet Needs
4.1 Overview
4.2 Optimal Antimicrobial Power
4.3 Enhancing Biologically Active Dressings
4.4 Minimizing Trauma and Pain at Wound Sites
4.5 Designing Multimodal Dressings
4.6 Advancing Indicators and Improving Diagnostic Power
4.7 Expanding Education and Awareness
5 Market Opportunity Analysis
5.1 Overview
5.2 Complementing Negative Pressure Wound Therapy
5.3 Engineering Dressings for Compression Therapy
5.4 Addressing Radiation Oncology Burns
5.5 Progressing Scar Management
5.6 Implementing Topical Drug Delivery
6 Market Drivers and Barriers
6.1 Drivers
6.1.1 Occurrence of Burns
6.1.2 Rising Rates of Diabetes
6.1.3 Aging Population
6.1.4 Rising Rates of Vascular Diseases
6.1.5 Rising Rates of Obesity
6.1.6 Need for Cost Savings
6.2 Barriers
6.2.1 Diminished Role of Advanced Dressings in Standard Therapies
6.2.2 Lack of Reimbursements
6.2.3 Complexities in Healthcare Systems
6.2.4 Regulatory Challenges
6.2.5 Lack of Clinical Data
6.2.6 Medical Device Excise Tax
6.2.7 Availability of Venture Capital
7 Competitive Assessment
7.1 Overview
7.2 Technology and Product Offerings
7.3 Product Profiles
7.3.1 Smith & Nephew
7.3.2 3M Health Care
7.3.3 Molnlycke Health Care
7.3.4 ConvaTec
7.3.5 Coloplast
7.3.6 Paul Hartmann
7.3.7 Systagenix Wound Management
7.3.8 Medline Industries
7.3.9 Laboratoires Urgo
7.3.10 BSN Medical
7.3.11 Covidien
7.3.12 B. Braun
7.3.13 Hollister
7.3.14 Derma Sciences
7.3.15 Lohmann & Rauscher
7.3.16 Advanced Medical Solutions
7.3.17 Nitto Denko
7.3.18 Winner Medical Group
7.3.19 DeRoyal Industries
7.3.20 Genewel
7.4 SWOT For Each Category
7.4.1 SWOT, Foams
7.4.2 SWOT, Hydrocolloids
7.4.3 SWOT, Semi-Permeable Films
7.4.4 SWOT, Hydrogels
7.4.5 SWOT, Alginates
7.4.6 SWOT, Hydrofibers
7.4.7 SWOT, Collagens
7.4.8 SWOT, Superabsorbents
7.4.9 SWOT, Wound Contact Layers
8 Pipeline Assessment
8.1 Overview
8.2 Product Profiles
8.2.1 MxBiodevices: Dermagrid
8.2.2 PolyNovo: NovoSorb BTM
8.2.3 Tissue Therapies: VitroGro ECM
8.2.4 Edixomed: ProNOx
8.2.5 KeraNetics: KeraStat
8.2.6 Arteriocyte: Magellan Bio-Bandage
8.2.7 Nanotherapeutics: NanoDOX
8.2.8 DeCell Technologies: DermGEN
8.2.9 Eqalix: OmegaSkin
9 Clinical Trials to Watch
9.1 Overview
9.2 Clinical Trial Profiles
9.2.1 Adocia
9.2.2 DermaPACE
9.2.3 Amnioexcel and DSC127
9.2.4 TransCu O2
9.2.5 Woundchek
10 Current and Future Players
10.1 Overview
10.2 Trends in Corporate Strategy
10.3 Company Profiles
10.3.1 Smith & Nephew
10.3.2 3M Health Care
10.3.3 Molnlycke Health Care
10.3.4 ConvaTec
10.3.5 Coloplast
10.3.6 Paul Hartmann
10.3.7 Systagenix Wound Management
10.3.8 Medline Industries
10.3.9 Laboratoires Urgo
10.3.10 BSN Medical
10.3.11 Covidien
10.3.12 B. Braun
10.3.13 Hollister
10.3.14 Derma Sciences
10.3.15 Lohmann & Rauscher
10.3.16 Advanced Medical Solutions Group
10.3.17 Nitto Denko
10.3.18 Winner Medical Group
10.3.19 Genewel
10.3.20 DeRoyal Industries
11 Strategic Competitive Assessment
11.1 Company Market Share
11.1.1 Company Share in 5EU Region
11.1.2 Company Share by Individual Country France Germany Italy Spain UK
12 Market Outlooks by Market Segment
12.1 Market Segment Share in the 5EU Region
13 Market Outlooks by Geography
13.1 France
13.2 Germany
13.3 Italy
13.4 Spain
13.5 UK
14 Appendix
14.1 Bibliography
14.2 Abbreviations
14.3 Report Methodology
14.3.1 Overview
14.3.2 Coverage
14.3.3 Secondary Research
14.4 Forecasting Methodology
14.5 Physicians and Specialists Included in This Study
14.5.1 Key Opinion Leaders
14.5.2 Primary Research Summary
14.6 About the Authors
14.6.1 Global Head of Healthcare
14.7 About GlobalData
14.8 Disclaimer

1.2 List of Figures
Figure 1: Usage Frequency of Antimicrobials
Figure 2: Influences on Product Adoption
Figure 3: Frequency of Advanced Dressing Usage Based on Brand
Figure 4: Influencers of Purchasing Decisions
Figure 5: Reimbursement Perceptions
Figure 6: Unmet Needs
Figure 7: 5EU Company Market Shares for Advanced Wound Dressings, 2013
Figure 8: France Company Market Shares for Advanced Wound Dressings, 2013
Figure 9: Germany Company Market Shares for Advanced Wound Dressings, 2013
Figure 10: Italy Company Market Shares for Advanced Wound Dressings, 2013
Figure 11: Spain Company Market Shares for Advanced Wound Dressings, 2013
Figure 12: United Kingdom Company Market Shares for Advanced Wound Dressings, 2013
Figure 13: 5EU Market Value Forecast by Market Segment for Advanced Wound Dressings, 2011–2021
Figure 14: 5EU Market Share Comparison by Country, 2014 & 2021
Figure 15: France Market Value Forecast by Market Segment, $m, 2011–2021
Figure 16: France Market Value Comparison by Market Segment, 2014 & 2021
Figure 17: Germany Market Value Forecast by Market Segment, $m, 2011–2021
Figure 18: Germany Market Value Comparison by Market Segment, 2014 & 2021
Figure 19: Italy Market Value Forecast by Market Segment, $m, 2011–2021
Figure 20: Italy Market Value Comparison by Market Segment, 2014 & 2021
Figure 21: Spain Market Value Forecast by Market Segment, $m, 2011–2021
Figure 22: Spain Market Value Comparison by Market Segment, 2014 & 2021
Figure 23: UK Market Value Forecast by Market Segment, $m, 2011–2021
Figure 24: UK Market Value Comparison by Market Segment, 2014 & 2021
Figure 25: Primary Research Participants By Country

Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

The market engineered data is verified and validated by a number of experts, both in-house and external.

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4450
USD $8900
USD $11645

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.